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Preface
In 2003, The Immigrant Learning Center, Inc. (ILC) launched a public education initiative to raise the visibility
of immigrants as assets to America. Spurred by certain anti-immigrant sentiments that were increasingly 
voiced since September 11, The ILC set forth to credibly document current economic and social contributions 
of immigrants.
Central to this effort are ILC sponsored research studies about immigrants as entrepreneurs, customers and workers.
To provide thoughtful and substantive evidence that immigrants are vital contributors to our nation, The ILC
commissioned university researchers to examine contributions of immigrants in their various roles and present 
those contributions within larger economic and social frameworks. The research approach included interviewing
immigrants and community informants and gathering relevant statistical data.
To date, five studies have been undertaken. “Immigrant Entrepreneurs and Neighborhood Revitalization” and
“Immigrant Homebuyers in Lawrence and Lowell, Massachusetts: Keys to the Revitalization of the Cities” were
published in December 2005. “Immigrant Entrepreneurs in the Massachusetts Biotechnology Industry” is the 
subject of this report. “The Rise of Asian-Owned Businesses” is a companion study to the biotechnology industry
study. A fifth study is underway about “Immigrant Workers in the Massachusetts Health Care Industry” and will
be ready fall 2007. Research team members were drawn from Boston University, Massachusetts Institute of
Technology, Tufts University and the University of Massachusetts Boston.
Collectively, these studies have reinforcing commonalities. They highlight unnoticed contributions of immigrants
to the economic development of communities. They identify immigrant businesses as engines for economic
growth in vital business sectors such as biotechnology and health care. Overall, immigrants are shown to be 
critical to the growth and development of Massachusetts.
The ILC hopes that these studies will raise the visibility of immigrants as contributors to our nation's economic
and social development. We also hope they will inform policy and promote thoughtful dialogue about key roles
played by immigrants in Massachusetts communities and in the overall economic development of the Commonwealth.
Diane Portnoy, Co-Founder and Director
The Immigrant Learning Center, Inc.
Marcia Drew Hohn, Director of Public Education
The Immigrant Learning Center, Inc.
June 2007
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Executive Summary
Purpose and Background of this Study
Immigration and developments in biotechnology are
two of the more prominent domestic issues facing
Americans in the early 21st Century. They are issues that
require understanding of the far-reaching demographic
changes in the United States and developments in 
scientific and technical knowledge relevant to human
health. Massachusetts is a setting particularly well-suited
to the study of the impact of both these phenomena.
The state has a well-deserved reputation for being one
of the preeminent locales for biomedical research and
product development in the United States. It also has
had the good fortune to become home for many 
immigrants in the last two decades. These immigrants
are often highly educated and carry well-honed 
entrepreneurial instincts. In this report we offer a 
preliminary look into the very real and congenial 
connection between these two important developments
—immigration and biotechnology.
One of the most significant demographic changes 
in the United States at the end of the 20th Century 
and early 21st Century has been the influx of new 
immigrants from Africa, Central and South America,
and the Far East. The number of foreign-born U.S. 
residents increased by 57 percent between 1990 and
2000.1 The result is that by 2005, 12.4 percent of the
U.S. resident population was foreign-born. 
The vigorous and ongoing debate over immigration
and its consequences for the United States has parallels
with a debate within the sciences related to federal 
policies dealing with the nationality of persons
employed in the U.S. scientific workforce. Specifically,
this debate is about who should have access to scientific
resources from higher education scholarships to 
multimillion dollar federal grants. The data that speak
to this debate are clear. Immigrants contribute to science
in large numbers and in high-quality research. About
one in four scientists in the U.S. workforce today is 
foreign-born. Furthermore, scientists in the U.S. who
are making exceptional contributions to their fields are
disproportionately foreign-born.2 
But are immigrants with advanced scientific backgrounds
also likely to be the entrepreneurs starting up the life
science-based firms that constitute the U.S. biotechnology
industry? This is the question that drove The Immigrant
Learning Center, Inc. (ILC) to commission this report.
Current research suggests that immigrants are indeed
significant contributors to the founding of high 
technology firms in the U.S. Two major studies on the
role of immigrant entrepreneurs in U.S. high technology
industries were released while this project was in
process. A study commissioned by Duke University
and the University of California at Berkeley found 
that 25.3 percent of U.S. science and engineering 
firms founded between 1995-2005 had at least one 
foreign-born founder. In Massachusetts, 29 percent 
of science and engineering firms were founded by 
the foreign-born.3 A second study, commissioned by 
the National Venture Capital Association, found that 
one-fourth of high technology firms are founded by 
immigrants. Even more dramatically, the study found
that publicly traded venture-backed firms founded by
immigrants have current market capitalization exceeding
$500 billion.4 These two recent studies cover the
national level and a broader spectrum of high technology
firms than those considered in the present report. 
This report focuses more narrowly and deeply on 
the role of immigrant founders in Massachusetts and 
New England biotechnology firms. 
1
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Major Findings
The findings suggest that the nationwide trend of
skilled immigrants creating high tech businesses is also
affecting the Massachusetts biotechnology industry. Among
the more striking conclusions about biotechnology firms
founded in New England are: 
• In 25.7 percent of these companies, at least one 
founder was foreign-born. 
• Biotechnology companies in New England with at 
least one immigrant founder produced over 
$7.6 billion in sales and employed over 4,000 
workers in 2006.
• Like the nationwide results for immigrant 
entrepreneurs in the biosciences, the founders of 
biotechnology firms in Massachusetts and 
New England come from nations across the globe. 
• However, foreign-born founders of biotechnology 
firms in Massachusetts, like high technology 
immigrant entrepreneurs nationwide, are more 
likely to come from Europe, Canada or Asia.
• About 12 percent of founders of Massachusetts 
biotechnology firms are women.
• Immigrant-founded biotechnology firms in 
Massachusetts are focused in Human Therapeutics 
and Genomics/Protemics. Human Therapeutics are 
treatments of disease. Genomics/Proteomics study 
the “map” of the human genome, which is our gene 
sequence, and the proteins that constitute genes to 
look for health applications.
• Immigrant entrepreneurs, therefore, specialize in the 
most complex, risky, life science-intensive aspects of 
biotechnology to seek knowledge directly applicable 
to human health.
This evidence strongly suggests that immigrants have
been key contributors to the creation of new businesses
and intellectual capital in the Massachusetts biotechnology
industry and the economic growth of the Commonwealth
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Background and Setting
The Biotechnology Industry in
Massachusetts and New England
The development of the life sciences has been heralded
as one of the most important human achievements
during the last half of the 20th Century. In June 2000,
Craig Venter, then CEO of the biotechnology firm
Celera Genomics, made a joint announcement with
U.S. Human Genome Project Director Frances Collins
that all 30,000 or so genes of our human DNA had
been mapped. With this and many other breakthroughs,
the life sciences have garnered increasing attention. Rapid
scientific advances have shown a promise for addressing
some of our long-standing and most challenging 
health problems. The development of an innovative 
biotechnology industry has brought the promise to
help us live longer and better. These innovations have
captured our attention and a great deal of investment
capital along the way.
The emergence of the biotechnology industry is a result
of the applications of life science discoveries like the
mapping of the human genome and the formation of
firms reliant on extensive collaboration for most of
their research and manufacturing breakthroughs. The
biotechnology industry is populated by small firms
which for the most part have not been acquired by larger
corporations as has happened in the pharmaceutical
industry. As befits an industry where organizations rely
on partnerships to succeed, many new start-ups trace
their origins to other biotechnology firms. Genentech
in South San Francisco and Millennium Pharmaceuticals
in Cambridge, Massachusetts, have been virtual incubators
for the geographic agglomeration of firms in these two
metropolitan areas with the largest concentration of
biotechnology companies. 
Although the promise of new science coming from
biotechnology sometimes leads to disappointing delays
and corresponding dips in stock market prices, small
knowledge-producing biotechnology firms have become
the model for larger pharmaceutical conglomerates to
emulate. This has become so much the case that
biotechnology has been publicly pursued by 41 
governors attempting to inject new life into their states.
Massachusetts has been a model to other states trying
to grow a similar thriving biotechnology industry.
Biotechnology as a for-profit enterprise has been located
in the United States generally and within California
and Massachusetts specifically. These states are home to
the greatest number of biotechnology firms in the world.
The Massachusetts Biotechnology Council lists 272
member biotechnology firms that are located in New
England. These companies form the population of firms
for this study.
Immigrants in Massachusetts
In addition to the biotechnology industry, Massachusetts
is also home to many recent immigrants. In 2005, 14.4
percent of Massachusetts residents were born outside of
the U.S., placing Massachusetts in the top ten states for
highest percentage of foreign-born residents.5 Of the
foreign-born residents in Massachusetts, 25.8 percent
were born in Europe, 27.2 percent were born in Asia and
37.6 percent were born in Latin America and Mexico. 
The purpose of this study is to research the connection
between these two growing communities in Massachusetts:
recent immigrants and the biotechnology industry. 
Are immigrants in Massachusetts helping to found 
new biotechnology firms or are these two trends largely
separate phenomena?
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Experiences of Immigrant
Entrepreneurs in Biotechnology
Successes of Immigrant Entrepreneurs
Both immigrants and entrepreneurs are risk-takers. 
But are immigrants in the United States also more 
likely to start a new business in the high-risk world of
biotechnology? What we have found thus far suggests
that immigrants make a disproportionate contribution
to biotechnology entrepreneurship in Massachusetts.
According to the U.S. Census, foreign-born residents of
Massachusetts are 14.4 percent of the total population.
But we find that 25.7 percent of biotechnology firms have
foreign-born founders. These immigrant entrepreneurs
hail from 23 different countries but most frequently
from the United Kingdom, India, Canada, China, Russia,
Greece and Israel.
Figure 1 shows prominently that there is a mixture of
immigrants from many countries. Slightly more immigrant
founders come from other English-speaking countries,
primarily the United Kingdom and Canada. Adding
Australia, New Zealand, Trinidad and Tobago brings
the percentage of foreign-born entrepreneurs from
Anglophone nations to only 27.9 percent of the total
immigrant founders. It is important to note that the
majority of entrepreneurs come from countries where
English is not the first language. Two of the world’s
most populous and fastest developing countries, India
and China, are well represented at 12 percent and eight
percent of the immigrant founders respectively. France,
Greece, Israel and Russia combined make up another
26 percent.
This study also gathered data on founder gender.
About 12 percent of the founders of biotechnology
industry firms in Massachusetts are women. Information
on the gender of founders is not available from the two 
previously mentioned national studies conducted on high
technology entrepreneurs, probably because of the small
numbers of women. However, based on the proportion
of women PhDs in the different fields (nearly half in 
the biological sciences compared to less than 20 percent
in engineering fields), we suspect that the number 
of female founders in Massachusetts biotechnology is
higher than in information technology and software
firms. We found no significant difference in the percent
of women founders between biotechnology firms with
at least one immigrant founder and those without
immigrant founders.
Figure 1 below shows the percentages of immigrant founders by country of origin. 
Armenia (1.3%)
Australia (1.3%)
Bulgaria (1.3%)
Canada (9.3%)
China (8%)
Denmark (4%)
Finland (1.3%)
France (8%)
Germany (4%)
Greece (5.3%)
Hungary (4%)
India (12%)
Israel (5.3%)
Italy (1.3%)
Japan (1.3%)
Korea (1.3%)
New Zealand (2.7%)
Russia (8%)
Sweden (1.3%)
Switzerland (1.3%)
Taiwan (2.7%)
Trinidad & Tobago (1.3%)
United kingdom (13.3%)
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What we have learned from interviewing several founders
of Massachusetts biotechnology companies is that the
concentration of biotechnology companies here is no
more an accident than is the presence of so many
immigrants in these companies, both as founders and as
employees. Both are the happy consequence of having
several excellent universities and research hospitals in
and around Boston. These institutions drew in scientists
who were already accomplished and went on to grow
several generations of new scientists and practitioners.
These men and women invented the biotechnology
industry in Massachusetts. Higher educational institutions
and major hospitals provided the excuse and resources 
for assembling them in the first place. Like all good
entrepreneurs, the young men and women attending
these institutions took it from there.
The firms founded by immigrant entrepreneurs are
likely to be small, employing fewer than 50 people and
having annual sales of under $20 million. This is true
of the biotechnology industry in general. An interesting
difference is that immigrant founders in Massachusetts
are more likely to have started biotechnology companies
that are in the most “science–intensive” category: human
therapeutics. These companies are working on discovering
the ways that genetic configurations can give clues about
therapies to treat human disease. For example, Biogen
Idec, a Massachusetts biotechnology company, has been
involved in developing Rituxan which is a therapy that
selectively depletes a particular kind of cell that is related
to non-Hodgkins lymphoma and rheumatoid arthritis.
Thus far, we have determined that two-thirds of the firms
with an immigrant founder have pursued knowledge
that would lead to therapies to treat human disease.
Less than half of other Massachusetts biotechnology
firms claim human therapeutics as a main pursuit. 
Hurdles to Entrepreneurship
The mere fact that one is a member of a minority 
population in the United States is often equated with
having difficulties in getting ahead and especially with
becoming a successful businessman or woman. Whether
one is talking about finding mentors, proper technical
assistance, access to capital or customers, minorities
often have a rougher time starting a business or growing
their enterprise. 
None of the persons interviewed for this report indicated
that starting their biotechnology firm had been easy.
Indeed, they made it very clear that they had worked
hard, sacrificed a great deal to get their firm up and
running and had no reason to imagine that they would
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Note: Total percentage is greater than one-hundred percent as many biotechnology firms specialize in multiple areas.
Agricultural Biotechnology
Bioinformatics
Biological Devices
Contract Manufacturing
Contract Research
Delivery
Environmental Biology
Genomics Proteomics
Human Diagnostics
Human Therapeutics
Industrial Biology
Marine Biology
Other
Platform
Veterinary
Figure 2 below shows the distribution of knowledge areas in which biotechnology firms specialize.
Immigrant-founded firms are compared to others.
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be successful. At the same time, their status as immigrants
or the children of immigrants had actually given them
several advantages in starting their venture that one
does not usually associate with minority businessmen
and women.
They spoke of the obligation they felt to friends and
family members almost as if it were an integral part 
of their business plan. And always, these obligations 
were put in the context of “the immigrant experience.” 
Hard work, sacrifice on behalf of some greater good, 
a sense of duty to people close to you and, importantly,
frugality were all part of a larger picture that brought
them to become entrepreneurs and carried them
through hard times. 
These “cultural” attributes found a congenial fit inside
universities where people just like them from a number
of different countries were encouraged to build on
these expressions of cultural capital in order to develop
their intellectual capital. The personal and professional
networks they developed while attending local 
universities proved invaluable in helping them identify
problems, potential products, investors, partners and
employees. Having access to smart people was important.
But what they brought to this experience was every 
bit as important as the training they got and the 
opportunities they were afforded by area institutions.
The immigrant and minority status of these would-be
inventors and business people ended up benefiting
them rather than serving as a distraction or impediment.
The promise of substantial returns on investment 
dollars may have “colored” the views of would-be backers
much more than the color of the skin of the young 
men and women who would become biotechnology 
entrepreneurs. But these immigrant and second-generation
minority scientists were able to “bank” on the personal 
networks they established while attending school here, 
every bit as much as 19th Century merchant princes had
banked on their personal contacts and ties to important 
local institutions.
Three Case Studies
This section of the report tells the stories of three companies
in the Massachusetts and New England biotechnology
field through the eyes of five founders (three 
first-generation immigrants and two second-generation).
1. Sridhar Iyengar and Sonny Vu, Co-Founders of AgaMatrix
AgaMatrix recently began to distribute what its 
co-founders Sonny Vu and Dr. Sridhar Iyengar call 
the “next generation” of blood glucose monitoring 
products for diabetes. They were instrumental in 
developing these products and are now manufacturing
them in Salem, New Hampshire. The origins of their
company can be traced to a summer science program
sponsored by the Department of Energy more than 15
years ago. 
Sonny and Sridhar didn’t meet at the summer science
program camp. That would have to wait until both
young men matriculated at the University of Illinois at
Champaign Urbana the following year. But, as Sridhar
recalls, a boyhood friend of his had attended the same
camp as Sonny and later told his friend about a really
bright and hardworking Vietnamese kid he’d met in
Oregon. Sridhar, a child of Indian immigrants, filed
the information away. He’d grown up in Knoxville,
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Tennessee, where his father worked for the Tennessee
Valley Authority. Sonny, himself an immigrant, had
lived in Oklahoma after arriving with his parents and
many other “boat people” who fled North Vietnam in
the late-1970s. Their chance meeting at a party and
subsequent friendship eventually led to the creation of
AgaMatrix more than a decade later.
They took separate paths after undergraduate school.
Sonny stopped working on his doctorate at Massachusetts
Institute of Technology in order to start a software
company. Sridhar, in the meantime, had attended
Cambridge University and finished his research on
biosensors. He joined Sonny’s company for a year before
it was sold. Following the sale of that company, and
instead of returning to finish his doctorate, Sonny decided
to work on a biosensor product line and the company
that Sridhar had in mind. This is the company that
eventually became AgaMatrix.
Founded in 2001, both men described it as a particularly
difficult time to be a start-up but, ironically, a great
time to begin a start-up. That’s because raising a second
wave of investment capital back then was a lot harder
than raising the initial capital. In their case, much of
that early financing came from contacts Sridhar had
made while studying in England and from one of 
the persons that had invested in Sonny’s software 
venture. Furthermore, with so many existing start-ups
tanking, there were a lot of good people looking for
work who were willing to take less pay than they’d 
been accustomed to earning. With their complementary
skills, Sonny handles the business development side of
AgaMatrix and Sridhar the science and product side.
With the discipline born of an immigrant upbringing,
AgaMatrix began to take shape. 
Of course, the early shape was fashioned or confined by
the fact that both men set up shop and lived out of a
cramped Somerville, Massachusetts, apartment. You don’t
splurge on fancy gadgetry, the newest equipment and
spacious offices when your daily lunch budget is $1.25.
But the very Spartan-like character of their operation
impressed would be investors who saw that these young
men knew how to work and wouldn’t waste their money.
Being in Boston and connected to Massachusetts
Institute of Technology were huge early advantages for
their fledgling company. Close to sources of student
interns, investment money and with serious academic
credentials in their own right, Sonny and Sridhar 
developed a smart team, worked cheaply and had a
product with a large potential market both in the
United States and internationally. By the time they
were ready to test out their ideas in a more formal 
setting, they couldn’t afford the lab space. Potential
institutional backers wanted too much equity in their
company to suit them. They were forced to find lab
space in Australia for six months where they 
made a couple of big scientific advances in what 
would become their product line. They also found
another collaborator.
Two years worth of “getting by” convinced them that they
should manufacture and distribute their product rather
than sell it off to a larger and more established company.
With their final investment capital lined up, their last
stop before taking their company over the border to New
Hampshire was a small lab in Cambridge, Massachusetts.
Sonny and Sridhar are convinced that their immigrant
backgrounds made the five years it took them to 
move from having a good idea to creating a product
line bearable, if not easy. The backing of their 
families (although more emotional than financial); the 
immigrant’s desire to “make it” and start his or her own
business; and the ability to find other like-minded
young men and women to work with (a great many of
them immigrants or the children of immigrants) 
greatly aided them in the struggle to start their 
business. It’s a different kind of immigrant success story
but not a new one.
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2. Krishna Menon, Founder of Kard Scientific
Dr. Krishna Menon started Kard Scientific in 2002 in
order to produce drugs to “alleviate pain and 
suffering.” His past experience working in global
pharmaceutical corporations gave him information
about how to develop and sell drugs. In starting his
own company, he was less driven by a profit motive
than to have greater scientific freedom to pursue health
applications where greater need exists in the world.
However, lacking the deep pockets of a pharmaceutical
giant and facing the difficulties of securing outside
investors have meant that the company has also 
had to take on contract research in order to “turn on 
the lights.” 
Dr. Menon’s mix of idealism and practicality was 
fostered at his mother’s knee. She was a physician in
India; as a boy he spent a great deal of time in her 
clinic learning medical procedures. He later withdrew
from medical school and went into the scientific
research side on the advice of his mother who felt that
there were not enough drugs in the world to treat 
people. Dr. Menon’s career took him all over the world.
He began in India selling veterinary products where he
also organized the company sports teams. Playing
cricket, he met the manager of the West Indies team
who also directed a veterinary services company in
Jamaica and hired Menon to work there. His next
move was to the Cayman Islands working in the 
ministry of agriculture on public health policy. In
1979, he went to Harvard University where he began
his “real research.” The move to Massachusetts was
facilitated by his wife’s parents living in Boston. After
his training, he moved out of state to work at two 
different large pharmaceutical companies making his
way up the corporate ladder.
When Dr. Menon began Kard Scientific, he chose
Massachusetts because of his connections in the 
scientific community here and the large talent pool.
The state did not provide any incentives to start the
business here. He does see hurdles to entrepreneurship
as an immigrant. Hearing an accent may put some 
people off, and there are those who tend to see 
stereotypes. These tendencies do not make obtaining
funding for a new venture, which he said is “very, very
hard,” any easier. Still, although he has begun working
on a small spin-out company in India, Dr. Menon
prefers leading a science-based company in the U.S.
Particularly here in Massachusetts, he can contact a
variety of people for technical information and other
“know-how” which would not be an option in many
other places. 
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3. Melina Fan and Benjie Chen, Co-founders of Addgene
Melina Fan and Benjie Chen are 30 year-old graduates
of Massachusetts Institute of Technology (MIT). Melina,
whose Chinese roots run four generations deep in
Boston, and Benjie, who came over with his family
after Tiananmen Square, met at MIT and were married
several years later. These days they divide their attention
between painting rooms in their new house and promoting
Addgene, the non-profit corporation they founded. 
Addgene was founded to help scientists share plasmids
which are valuable DNA-based materials used for 
biomedical research. When a scientist makes a new 
discovery about a gene, other scientists will want to
build on those findings. They will write to the original
scientist and ask the scientist to send them a plasmid
containing the gene. Scientists share these tools with
their colleagues in order to find life-saving cures. Every
laboratory has its own area of expertise, and progress is
made through working together.
However, the old system of plasmid sharing placed a
tremendous burden on the laboratories that make
groundbreaking discoveries. The time spent fulfilling
the many requests took time away from their research.
Oftentimes, they were simply too busy to respond to
requests and, therefore, the plasmids were sent several
months later or were never sent. This slowed the progress
of research.
The idea for Addgene grew from Melina’s thesis work on
a protein involved in diabetes. In her initial experiment,
she found 20 proteins that interacted with her protein
of interest and were potentially important for diabetes.
When she wrote to other scientists to request the 
plasmids encoding these proteins, only half of the 
scientists sent the materials. Spurred by this negative
experience, Melina decided to start an organization to
help scientists share their materials more efficiently. 
Benjie appreciated the problem that Melina had run up
against. As a budding computer scientist, he also saw it
as an opportunity to put his computer work to good
use in the service of biology. Melina’s brother came on
board to handle the business side of the operation.
They started Addgene in 2004, though Benjie quickly
added that the need for this kind of service had 
been “out there” for two decades. Cutbacks in federal 
support for this kind of work really stalled their
progress. They used money from a fund established by
Melina’s grandmother for everyday expenses and lived
in her mother’s house for a year. Some timely donations
to get their operation up and running came in handy.
Harvard University gave them good rates on lab 
space and manages all the facilities. The Massachusetts
Biotechnology Council helped them a great deal.
Friends from their undergraduate days are working
with them as well.
With thousands of labs in the United States and many
more overseas, there’s certainly a need for the service that
Addgene provides. The idea of sharing and collaboration
is at the heart of the scientific enterprise. Getting started
wasn’t going to be easy, however. Fortunately for them,
the number of labs at Harvard University and the Boston 
area provided them with a good foundation upon
which to build. 
After two and a half years, they are finally breaking
even. So far, 250 labs have deposited a total of 4,500
plasmids to Addgene’s repository, but that’s a very small
number compared to the potential market. They expect
to see substantial growth over the next few years as
9
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more laboratories send materials to them. There are
thousands of labs overseas with Europe and China
leading the way and Japan and Korea moving up 
quickly. Still, the United States remains the biggest
market. In addition, the law on intellectual property is
better developed here than in other parts of the world. 
While their ties to the local Chinese community are
indirect through Melina’s mother, who is very active in
Boston’s Chinatown, there is an unmistakable connection
between them and the larger community of foreign 
students and researchers that have come to the Boston area.
Indeed, they doubt very much that Addgene could
have been launched in any place other than the Boston
area, in large part because of the concentration of 
biology research labs and foreign talent. 
Having been brought up in socialist China and having
spent most of his adult life in undergraduate and 
graduate schools, Benjie has embraced the opportunity of
starting a non-profit venture as a chance to learn how
to make money and be an entrepreneur. A big shock to
him was “the amount of legal stuff you had to know.”
With hard work, persistence and luck, Melina and
Benjie believe Addgene will overcome any challenge to
its growth. If it does, the international marketplace in
science will never be the same. 
Implications for
Massachusetts and Beyond
The purpose of this study was to investigate the 
contribution of foreign-born entrepreneurs to the
Massachusetts biotechnology industry.
Our data shows that at least one immigrant was
involved in founding 25.7 percent of all biotechnology
firms in New England with most firms located in
Massachusetts. Our percentage may be slightly lower
than the national study by Wadhwa et al. They looked
only at Massachusetts companies founded since 1995,
finding that 29 percent had an immigrant founder.
However, we studied all firms in the Massachusetts
biotechnology industry regardless of founding date.
The majority of immigrant-founded companies are more
recent. A dramatic perspective arises when looking only
at the firms for which we were able to obtain data on
immigrant status of founders. There we found about
40 percent of the biotechnology firms in Massachusetts
and New England had at least one immigrant founder.6
The pool of immigrant-founded companies is
responsible for contributing an estimated 
$7.6 billion in revenue and 4,352 jobs to the 
New England economy in 2006. Immigrant 
entrepreneurs are more likely to found biotechnology
firms that specialize in human therapeutics, the
most science-intensive area of biotechnology
which seeks to develop cures for human diseases.
In Massachusetts and New England, biotechnology 
is an important industry for current and future 
economic growth. It is a small field with a large footprint.
While there are fewer workers employed in biotechnology,
the jobs are highly skilled and contribute to the knowledge
economy. Manufacturing provides about 297,000 jobs;
transportation and utilities about 572,000 jobs; and
financial services about 225,000 jobs. However, these
sectors are either stable or declining in employment 
and market share.7 Biotechnology, together with high 
technology generally, is an area that promises to spur
economic growth into the future. This is not to say that
there are no risks involved in the pursuit of such 
knowledge-based industries. The outcomes of scientific
research are uncertain. Nevertheless, having a region
that provides the best available resources, including
drawing in many of the world’s brightest minds, gives
Massachusetts an edge in this high-risk, high-reward field.
This research finds that U.S. immigrants are an important
component of one of the “crown jewels” of the nation’s
innovative contributions to the global economy.
Biotechnology was not only born in the U.S. but has
flourished here, particularly in Massachusetts and
California. The solutions to some of the worst health
crises that humanity faces may well be found right here
in Massachusetts in a company started by an immigrant.
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Appendix: Data and Methodology
The purpose of this study is to examine the impact of immigrants in the Massachusetts biotechnology sector. 
In order to do so, we compiled a list of biotechnology firms in Massachusetts and the surrounding New England
states. We were interested in companies based in New England that are not large, multinational pharmaceutical
companies. We further limited our examination to include only independent companies; subsidiaries and local
branches of larger firms were excluded. We then attempted to identify the founders, the countries of origin of
each firm and other information about the firm itself.
Company Data
Companies included in the study were drawn primarily from the member list of the Massachusetts Biotechnology
Council (MBC). The MBC member list includes a total of 341 firms classified as biotechnology firms. 
In addition, seven firms were included in this study whom the Boston Business Journal listed as Massachusetts
biotechnology firms but were not listed as members of the MBC. Of these 348 firms, eighty-seven were eliminated
from the study for one or more of the following reasons: firm is a subsidiary of a larger company; firm was founded
outside of New England; or firm is a large, multinational pharmaceutical company such as Merck or Wyeth.
We then gathered financial information for the remaining 261 firms. The collection of financial information was
problematic as there is no one, authoritative source that provides financial data on all firms. This problem was
further compounded by the fact that private firms are not required to provide financial information to the 
public. The public firms were less problematic as they are required to provide the Security and Exchange 
Commission with their financial information. We collected information on public firms using Mergent Online, 
a database that gathers a variety of information from public filings. For the private firms, we referenced a variety
of sources: Reference USA, an online database; Ward’s Business Directory of U.S. of private and public 
companies, a printed volume listing information on many U.S. firms; and LexisNexis Business Search, a search
engine linked to a variety of public reports on businesses. In the majority of instances, we were unable to find 
specific financial information on the private firms. Instead, many sources listed estimates.
Due to the variety of sources, there were often inconsistencies across sources in what data was available for each
firm. We were primarily interested in firm revenues, but this was often unavailable. In such cases, we relied on
sales, estimated sales or, in a few cases, net income.
Finally, in order to get a sense of the size of the firm, we examined each firm’s number of employees. Both the
Massachusetts Biotechnology Council and the Boston Business Journal provided this information.
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Founder Information
We used three methods to gather founder information. First, we emailed each company asking for names and
countries of origin for each founder. This method was largely unsuccessful; only a few firms responded to our
inquiries. Second, we examined each company’s website. Many company websites provide a history of the firm
that lists the names and biographies of the company’s founders. Other companies provide extensive biographies
of their key personnel including company founders. We also found many instances where an individual’s 
biography on one site would list that person as a founder of another firm. Unless such information was directly
contradicted by the second firm’s website, we included the information. Unfortunately, gathering information this
way was problematic. In cases where we drew information from biographies of key personnel, we had no way of
knowing whether or not all founders were listed. If a founder had left the firm by the time we looked at the web
site then his or her biography would likely have been removed. Therefore, we had no way of knowing whether or
not our information was complete.
Determining a founder’s country of origin was also problematic. In some cases, the founder’s country of origin
was listed in the company’s history or in his or her biography. In most instances, though, this information was
not provided. In such cases, we assigned country of origin based on the founder’s educational background. If the
founder was educated overseas, we counted that person as an immigrant; otherwise, the founder was listed as 
a non-immigrant. In cases where the founder received degrees from both American and non-American 
institutions, we used the lowest degree to assign country of origin. For example, if a founder got a master’s degree
in India and a doctorate in the United States, then we listed that person as an immigrant.
After emailing and searching company websites, there remained 166 companies for which we had incomplete or
no data. We called these remaining companies directly and asked company representatives for the information.
We followed the following script during each telephone call:
Hello, my name is Jim McQuaid, and I’m calling from the Boston University Department of Sociology. 
We’re conducting a research study looking at the founders of New England biotechnology firms. Would you have
a few moments to answer some questions about the founders of [company name]?
1. What were the names of the founders of [company name]?
2. Their genders?
3. Were any of your company’s founders immigrants to the United States?
In many instances, we had to leave messages with administrative staff or on voicemail. We made a total of three
attempts to contact each company.
13I M M I G R A N T  E N T R E P R E N E U R S  I N  T H E  M A S S A C H U S E T T S  B I O T E C H N O L O G Y I N D U S T R Y
43079txt_r1  6/5/07  9:58 AM  Page 21
Interview Data
We interviewed five founders of three different New England biotechnology companies for this research. 
Four founders were male and one was female. The founders immigrated from China, Vietnam, and India. 
The interview questions included the following information:
• Educational background
• How respondent came to live in the United States
• Founding role in biotechnology company
• Company business and history
• Reasons for locating in Massachusetts 
• Advantages and disadvantages of immigrant status for being an entrepreneur
• Role of funding in start-up
• Role of gender in entrepreneurship
• Participation in support groups for immigrants and/or entrepreneurs
• National styles of science
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